Agreed mopar...unless and until Odidi finds a way to unlock the potential inherent value in IPCI's NDA's and/or his nPODDS and PODRAS hyper-matrix proprietary delivery tech platforms the entire generics line is irrelevant to the true potential success here 100% agreed!!!